UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

Cancer discovery, 2017-01, Vol.7 (1), p.54-71

2017

Volltextzugriff (PDF)

Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression

Cancers, 2021-02, Vol.13 (4), p.692

2021

Volltextzugriff (PDF)

Microglial amyloid beta clearance is driven by PIEZO1 channels

Journal of neuroinflammation, 2022-06, Vol.19 (1), p.147-147, Article 147

2022

Volltextzugriff (PDF)

Using online game-based platforms to improve student performance and engagement in histology teaching

BMC medical education, 2019-07, Vol.19 (1), p.273-11, Article 273

2019

Volltextzugriff (PDF)

Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition

Clinical cancer research, 2017-11, Vol.23 (22), p.6923-6933

2017

Volltextzugriff (PDF)

Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells

Molecular cancer therapeutics, 2010-12, Vol.9 (12), p.3175-3185

2010

Volltextzugriff (PDF)

Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NFκB-signaling

Oncoimmunology, 2024-12, Vol.13 (1), p.2393442

2024

Volltextzugriff (PDF)

Regulation of tumor cell plasticity by the androgen receptor in prostate cancer

Endocrine-related cancer, 2015-06, Vol.22 (3), p.R165-R182

2015

Volltextzugriff (PDF)

High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

Clinical cancer research, 2009-10, Vol.15 (19), p.6070-6078

2009

Volltextzugriff (PDF)

Fanconi anemia pathway regulation by FANCI in prostate cancer

Frontiers in oncology, 2023-10, Vol.13, p.1260826-1260826

2023

Volltextzugriff (PDF)

Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells

PloS one, 2012-12, Vol.7 (12), p.e51470

2012

Volltextzugriff (PDF)

BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation

Oncogene, 2020-03, Vol.39 (11), p.2391-2407

2020

Volltextzugriff (PDF)

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion

Oncotarget, 2013-01, Vol.4 (1), p.48-63

2013

Volltextzugriff (PDF)

The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells

Molecular cancer research, 2019-11, Vol.17 (11), p.2154-2168

2019

Volltextzugriff (PDF)

Arachidonic Acid Pathway Members PLA2G7 , HPGD , EPHX2 , and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer

The American journal of pathology, 2011-02, Vol.178 (2), p.525-536

2011

Volltextzugriff (PDF)

Axon Guidance-Related Factor FLRT3 Regulates VEGF-Signaling and Endothelial Cell Function

Frontiers in physiology, 2019-03, Vol.10, p.224-224

2019

Volltextzugriff (PDF)

CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells

Cells (Basel, Switzerland), 2019-03, Vol.8 (3), p.276

2019

Volltextzugriff (PDF)

DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2

Communications biology, 2024-01, Vol.7 (1), p.108-108, Article 108

2024

Volltextzugriff (PDF)

PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A―Mediated Inactivation in Human Malignant Glioma

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.2870-2877

2009

Volltextzugriff (PDF)

Thermal dose as a universal tool to evaluate nanoparticle-induced photothermal therapy

International journal of pharmaceutics, 2020-09, Vol.587, p.119657-119657, Article 119657

2020

Volltextzugriff (PDF)

Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress

British journal of cancer, 2012-01, Vol.106 (1), p.99-106

2012

Volltextzugriff (PDF)

M1 Macrophages Induce Protumor Inflammation in Melanoma Cells through TNFR–NF-κB Signaling

Journal of investigative dermatology, 2022-11, Vol.142 (11), p.3041-3051.e10

2022

Volltextzugriff (PDF)

Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity

Cancer research (Chicago, Ill.), 2021-10, Vol.81 (19), p.4901-4909

2021

Volltextzugriff (PDF)

Abstract 4106: Lyn kinase promotes metastasis through EMT in cancers

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4106-4106

2015

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(50)
Buchkapitel
(2)

Sprache

Englisch
(52)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression

Microglial amyloid beta clearance is driven by PIEZO1 channels

Using online game-based platforms to improve student performance and engagement in histology teaching

Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition

Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells

Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NFκB-signaling

Regulation of tumor cell plasticity by the androgen receptor in prostate cancer

High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

Fanconi anemia pathway regulation by FANCI in prostate cancer

Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells

BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion

The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells

Arachidonic Acid Pathway Members PLA2G7 , HPGD , EPHX2 , and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer

Axon Guidance-Related Factor FLRT3 Regulates VEGF-Signaling and Endothelial Cell Function

CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells

DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2

PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A―Mediated Inactivation in Human Malignant Glioma

Thermal dose as a universal tool to evaluate nanoparticle-induced photothermal therapy

Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress

M1 Macrophages Induce Protumor Inflammation in Melanoma Cells through TNFR–NF-κB Signaling

Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

Abstract 4106: Lyn kinase promotes metastasis through EMT in cancers

Suchergebnisse filtern